outsourcing clinical trials to CROs

Outsourcing Clinical Trials to CROs: A Trend or Here to Stay?

Many times the term “outsourcing” invokes a negative response, but at the Fierce Biotech 2017 conference hosted this year in Boston, outsourcing was a key topic of positive conversations. One of the main takeaways was that when it’s done thoughtfully, a sponsor company outsourcing clinical trials to CROs can provide beneficial access to therapeutic and…

gene therapy trials

Conference Highlights Importance of Overcoming Logistical Challenges to Support Gene Therapy Trials

With its potential to eliminate and prevent hereditary diseases like cystic fibrosis and hemophilia, gene therapy has the potential for never-before-seen medical breakthroughs.  Despite this, there has not yet been a single approved human gene therapy product available to the US market. Nonetheless, the amount of gene therapy research and development continues to skyrocket.  …